BioSpace News Archive

Analysis supports ensifentrine’s efficacy in COPD as monotherapy and on top of standard of care treatment in patients who remain symptomatic Six abstracts accepted demonstrating ensifentrine’s potential across treatment settings and formulations LONDON, May 01, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that six abstracts presenting clinically relevant findi

Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced it has expanded its presence in Iowa through its partnership with John H. Wollner, MD..

ALJ recommends exclusion and cease and desist order against infringing 3Shape products

Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced financial results for the first quarter ended March 31, 2020 and provided an update on its strategic process.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the retirement of Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, which was previously planned and disclosed, after a more than 30-year career in biotechnology and pharmaceutical research, development, and sales and marketing.

Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the first quarter of fiscal year 2020 after the market close on Monday, May 11, 2020.

DENTSPLY SIRONA Inc., The Dental Solutions Company™, announced that the Company will host an investor conference call and live webcast on Thursday, May 7, 2020 at 8:30 am ET and send out an earnings press release earlier that morning.

On May 15, the Tuberous Sclerosis Alliance (TS Alliance) will join tuberous sclerosis complex (TSC) organizations around the world to observe the eighth annual TSC Global Awareness Day. On this day, thousands of individuals and families affected by TSC will come together to increase public awareness of the rare disease and share the

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the first quarter 2020 financial results and provide a corporate update on Thursday, May 7, 2020 at 4:30 p.m. Eastern/1:30 p.m. Pacific. Conference Call and Webcast: Thursday, May 7, 2020 @ 4:30 p.m. Eastern/1:30 p.m. Pacific

Hillrom Supports Global COVID-19 Response With New Critical Care Products and Expanded Production Company Provides Financial Update on COVID-19